625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update. - Mourey, L.; Conter, H.J.; Shore, N.; Berry, W.R.; Fong, P.C.; Piulats, J.M.; Appleman, L.J.; Todenhöfer, T.; Gravis, G.; Laguerre, B.; Gurney, H.; Retz, M.; et al. (Annals of Oncology, 2020)